Giant cell granuloma of the jawbones – a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factor
Authors:
- 9 October 2006
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 35 (10) , 613-619
Abstract
Aim: To estimate the angiogenic activity in central giant cell granuloma (CGCG) by immunohistochemical stains for vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). VEGF and bFGF immunoreactivity of the lesional mononuclear (MC) and giant (GC) cells was also investigated.Method: The study consisted of 41 cases of CGCG. Vascularity was quantified by microvascular volume (MVV) as determined by point counting. In five cases of CGCG, regions at the surrounding border, which demonstrated reactive vascular‐rich inflammatory areas, served as control. Immunoreactivity of the MC and GC was assessed as the percentage of VEGF‐ and bFGF‐positive cells from the total number of the respective cell type.Results: Within CGCG lesions the extent of angiogenesis was low; MVV did not exceed 5% for either VEGF (88% of lesions) or bFGF (78% of lesions). The mean MVV of VEGF‐ and bFGF‐positive blood vessels was 2.9% ± 2.4% and 3.46% ± 2.35%, respectively, significantly lower than in the control areas (27.5% ± 7.3% and 28.08% ± 5.5%, respectively) (P = 0.043). VEGF‐positive and bFGF‐positive MC and GC were found in nearly all lesions and in less than half of the lesions, respectively.Conclusion: The low mean MVV of VEGF‐ and bFGF‐positive blood vessels implies low angiogenic activity, which does not support the designation of CGCG as a true proliferative vascular lesion. MC and GC immunoreactivity for the angiogenic factors is assumed to play an important role in the osteoclastogenesis process, thus contributing to additional growth of the CGCG lesions.Keywords
This publication has 21 references indexed in Scilit:
- The biology of VEGF and its receptorsNature Medicine, 2003
- Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jawJournal of Oral Pathology & Medicine, 2003
- Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumorsVirchows Archiv, 2002
- VEGF and the quest for tumour angiogenesis factorsNature Reviews Cancer, 2002
- Basic Fibroblast Growth Factor Stimulates Osteoclast Recruitment, Development, and Bone Pit Resorption in Association With Angiogenesis In Vivo on the Chick Chorioallantoic Membrane and Activates Isolated Avian Osteoclast Resorption In VitroJournal of Bone and Mineral Research, 2002
- Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2aPediatrics, 1999
- Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.Journal of Clinical Investigation, 1996
- Immunohistochemical and ultrastructural evidence of a modified microvasculature in the giant cell granuloma of the jawsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1995
- Central giant cell lesions of the jawsOral Surgery, Oral Medicine, Oral Pathology, 1993
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989